Law Firm Probes Option Care Health Over Shareholder Rights
Monteverde & Associates is investigating Option Care Health amid potential shareholder concerns. The M&A-focused class action firm has recovered millions for investors.
A New York-based class action law firm has launched an investigation into Option Care Health, Inc. (NASDAQ: OPCH), raising questions about whether the home infusion therapy company's shareholders are being adequately protected, according to an announcement dated Oct. 11, 2026.
Monteverde & Associates PC, led by class action attorney Juan Monteverde, disclosed the probe. The firm describes itself as focused on merger and acquisition litigation and was recognized as a Top 50 firm in the 2025 ISS Securities Class Action Services Report, a benchmark ranking within the securities litigation industry.
Read more Monteverde & Associates Probes Pacira BioSciences Merger Deal →
The firm has previously recovered millions of dollars on behalf of shareholders in similar investigations, though no specific claims or findings against Option Care Health have been established at this stage. Investigations of this kind typically precede potential litigation and are often triggered by concerns about corporate transactions, board decisions, or the adequacy of disclosures to investors.
Option Care Health, listed on the Nasdaq under the ticker OPCH, operates in the home and alternate-site infusion services sector. The investigation signals that at least one prominent plaintiffs' firm believes there may be grounds to scrutinize recent corporate activity at the company on behalf of its investor base.
Shareholders who believe they may have relevant information or who wish to learn more about their legal rights are generally encouraged to contact the investigating firm directly. Continue reading at All Financial Services & Investing.
